FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel guanidines of the formula (I): where addition to pyridine ring is carried out at 3 or 4 position; R means one or more substitutes that can be similar or different and taken among group consisting of hydrogen, halogen atom or alkoxy-group; X means a single bond, substituted C3-C7-cycloalkylene, arylene, one or two sulfur atoms; Q1 and Q2 mean C1-C10-bivalent linear or branched hydrocarbon radical. Compounds of the formula (I) inhibit unfavorable cells proliferation and can be used in medicine. EFFECT: improved methods of synthesis, valuable medicinal properties of compounds. 9 cl, 2 tbl, 19 ex
Authors
Dates
2002-12-27—Published
1998-05-15—Filed